Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperthermia × Temozolomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 391 Brain Neoplasms 161 Glioma 155 Gliosarcoma 128 Astrocytoma 111 Central Nervous System Neoplasms 108 Melanoma 75 Oligodendroglioma 73 Neuroblastoma 44 Neoplasms 33 Medulloblastoma 33 Neoplasm Metastasis 29 Recurrence 28 Ependymoma 25 Sarcoma 23 Sarcoma, Ewing 22 Rhabdomyosarcoma 18 Small Cell Lung Carcinoma 16 Lymphoma 16 Carcinoma, Non-Small-Cell Lung 16 Diffuse Intrinsic Pontine Glioma 15 Ovarian Neoplasms 14 Lung Neoplasms 14 Breast Neoplasms 14 Neuroendocrine Tumors 13 Choroid Plexus Neoplasms 13 Optic Nerve Glioma 11 Neuroectodermal Tumors, Primitive 11 Spinal Cord Neoplasms 10 Rhabdoid Tumor 10

Interventions

Diathermy 20 Radiotherapy 10 Cisplatin 5 Fluorouracil 4 Drug Therapy 4 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Immunotherapy 2 Hyperthermia, Induced 2 Doxorubicin 2 Conization 2 Capecitabine 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Temozolomide 1 Surgical Procedures, Operative 1 Solutions 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06271421 2024-02-26

ANCHIALE

Poznan University of Medical Sciences

Phase NA Recruiting

Hyperthermia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡